Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • lecanemab

Tag: lecanemab

Leqembi five-year data infographic with CDR-SB benefit and ARIA figures
  • Pharmaceuticals

Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening

Megan Wood28 minutes ago010 mins

Five years of continuous lecanemab left patients 2.05 CDR-SB points better than an untreated cohort, while ARIA risk fell after year one. What the CTAD 2026 data mean for Eisai and Biogen.

Read More

Categories

  • Healthcare IT (26)
  • Industry Insights (358)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (106)
  • Uncategorized (1)

Recent Posts

  • Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech
  • Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening
  • Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California
  • Seawolf Therapeutics Launches With $100M and a Sanofi Deal to Make DNA Medicines Redosable
  • Teva Price-Fixing Settlement: 45 States Strike Deal in Generic Drug Collusion Case
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.